SCHEMBL26229683

SCHEMBL26229683

COC(=O)C(CNC(=O)c1ccnc(CBr)c1)CNC(=O)c1cc(CBr)nc(CBr)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ GAA P10253 2/20 0.35
▸ F10 P00742 1/20 0.35
▸ PRSS1 P07477 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ KDM5A P29375 1/20 0.35
▸ KDM5C P41229 1/20 0.35
▸ TAS1R3 Q7RTX0 1/20 0.34
▸ TAS1R1 Q7RTX1 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ WDR5 P61964 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25181401 0.90 F10 (0.38) KMT2AGAAF10PRSS1HSD17B10
SCHEMBL26229684 0.87 KDM4E (0.37) KDM5BKMT2AGAAHSD17B10ALDH1A1
SCHEMBL26228739 0.80 HSD17B10 (0.37) KMT2AGAAHSD17B10MEN1ALDH1A1
SCHEMBL25186961 0.79 F10 (0.38) KMT2AGAAF10PRSS1HSD17B10
SCHEMBL26228742 0.79 F10 (0.38) KMT2AGAAF10PRSS1HSD17B10
SCHEMBL25182494 0.77 TAS1R3 (0.45) TAS1R3TAS1R1
SCHEMBL25182492 0.76 GAA (0.35) KMT2AGAAHSD17B10ALDH1A1KDM4E
SCHEMBL26230874 0.74 GAA (0.42) KMT2AGAAHSD17B10ALDH1A1KDM4E
SCHEMBL30378291 0.72 KDM4C (0.55) KDM5BALDH1A1KDM4EKDM5AKDM5C
SCHEMBL1287072 0.72 KDM4C (0.55) KDM5BALDH1A1KDM4EKDM5AKDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230277678-A1 COMPOUNDS CAPABLE OF BINDING TO PROTEINS AND CONJUGATES OBTAINED FROM THESE COMPOUNDS MC SAF (FR) 2023-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230277678-A1 COMPOUNDS CAPABLE OF BINDING TO PROTEINS AND CONJUGATES OBTAINED FROM THESE COMPOUNDS SHBG, SERPINA6, F13B KDM5B 3630/4885KMT2A 4179/4885GAA 1690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback